Low-dose targeted radionuclide therapy synergizes with CAR T cells and enhances tumor response is a research paper published in Frontiers in Immunology (2024). On theSindex it has a DataRank of 0. It has been cited 12 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NCI NIH HHS
Grant: R01 CA217059
NCI NIH HHS
Grant: R01 CA254035
National Institutes of Health
Grant: 5R01CA217059-02
Imaging-guided fine tuning of CAR T cell affinity to limit T cell cytotoxicity to tumor antigen
National Institutes of Health
Grant: 1R01CA254035-01A1
CAR T Cells for Advanced Thyroid Cancer
FWCI
2.10
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals